Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Rating of “Moderate Buy” from Brokerages
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has been given an average rating of “Moderate Buy” by the eight analysts that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price target […]
More Stories
TD SYNNEX (NYSE:SNX) Stock Price Up 5.4% – Should You Buy?
Shares of TD SYNNEX Co. (NYSE:SNX – Get Free Report) were up 5.4% on Friday . The stock traded as...
Endeavour Silver (NYSE:EXK) Trading 6.2% Higher – Should You Buy?
Endeavour Silver Corp. (NYSE:EXK – Get Free Report) (TSE:EDR) shot up 6.2% during mid-day trading on Friday . The company...
LyondellBasell Industries (NYSE:LYB) Shares Purchased by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its holdings in LyondellBasell Industries (NYSE:LYB – Free Report) by 20.2% during the 4th quarter, according...
Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO) Shares Bought by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO – Free Report) by 98.5%...
Ridgewood Investments LLC Decreases Holdings in Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV)
Ridgewood Investments LLC trimmed its stake in shares of Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV – Free Report)...
Smith & Nephew plc (NYSE:SNN) Stock Position Lifted by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 6.1% during...